Spin-out company ReactivLab is to commercialise the new animal health diagnostic technology developed in the University’s Faculty of Veterinary Medicine. ReactivLab will provide services and kits that can detect sub-clinical symptoms of inflammation, infection and disease in both companion and farm animals. These tests can allow pet owners or farmers to know if their animal is unwell before any visible symptoms appear enabling early intervention with the best treatment.
IP Group plc, the intellectual property commercialisation company, has invested £450,000 in ReactivLab Ltd for a 33.2% stake.
ReactivLab’s new diagnostic approach exploits blood proteins known as acute phase proteins (APPs). Acute phase proteins (APP) are a group of blood proteins that change in concentration in animals subjected to challenges such as infection, inflammation, surgical trauma or stress. Quantification of their concentration can provide diagnostic and prognostic information. The university have identified specific APPs (and combinations) that act as biomarkers to detect the presence of disease or poor health before visible symptoms appear.
Professor David Eckersall, scientific founder of ReactivLab, is a world-leading researcher in the area of acute phase proteins in animals co-ordinating the European Concerted Action Group on Acute Proteins in Animals. He has specialised in this field for over 20 years and has presented the findings of his work at international scientific meetings throughout the world. He is a Professor of Veterinary Biochemistry at the Faculty of Veterinary Medicine at the University of Glasgow and has been responsible for many of the major advances in monitoring the APP response in domestic animals such as dogs, cats, cattle and pigs. He has also invented novel methods for analysis and discovered new applications for the diagnostic use of APP showing the benefit of measuring the proteins in a variety of conditions including bovine mastitis and pneumonia, feline infectious peritonitis and canine leukaemia.
ReactivLab will exploit this research and provide services in diagnostic testing for acute phase proteins. For example, blood samples from dogs and cats can be analysed to assist in the very early diagnosis of diseases such as arthritis, cancer and various infectious diseases. Diagnostic kits are also planned to make the approach available world-wide.
APP testing will not only give the opportunity for vets to intervene with treatments before a condition has advanced significantly they will also provide animal owners with a means to monitor animal health on a regular basis.
ReactivLab is the third spin-out from IP Group’s partnership with the University of Glasgow which was announced in October 2006. The first two companies from the collaboration are XanIC Limited, which is commercialising a new semiconductor process technology, and Wireless bioDevices Limited, which was established to commercialise wireless sensor technology for use in medical diagnostics.
The diagnostic test technology has already received Synergy Fund investment via a £200,000 loan from the Fund to the University for pre-incorporation development. Synergy Fund is a Glasgow/Strathclyde university Fund managed by Scottish Equity Partners (SEP). ReactivLab has also received a Scottish Executive SMART Award.
Alan Aubrey, Chief Executive of IP Group, said: “We are delighted with the progress being made at Glasgow. ReactivLab is the first spin-out we have completed in the exciting and growth area of animal health but is the third spin-out from Glasgow within the first year that IP Group partnered with the University.”
Prof Steve Beaumont, VP Research & Enterprise, commented: “The University is very pleased that research carried out on our internationally renowned Faculty of Veterinary Medicine has led to a spinout that will assist in the diagnosis of diseases in animals. This substantial investment from IP Group in addition to earlier support from the Synergy Fund recognises the confidence we have in the future success of the business. As we expected our collaboration with IP Group has accelerated our spin-out process and we are delighted to announce the formation of a third company so soon after our partnership was launched.”
Prof David Eckersall, Director, ReactivLabs, said: “Establishing ReactivLab will allow the acute phase protein tests to become widely available so that instead of being restricted to our research programmes their full benefit in being able to detect even sub clinical disease in dogs and cats will be available to the pet owning community at large.”
Martin Shannon | alfa
Trees and climate change: Faster growth, lighter wood
14.08.2018 | Technische Universität München
Animals and fungi enhance the performance of forests
01.08.2018 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
16.08.2018 | Life Sciences
16.08.2018 | Earth Sciences
16.08.2018 | Life Sciences